| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | REMEDYREPACK INC. | 20260602 | 1 |
| GLYCOPYRROLATE TABLETS USP | Golden State Medical Supply, Inc. | 20260527 | 9 |
| These highlights do not include all the information needed to use QBREXZA ® safely and effectively. See full prescribing information for QBREXZA. QBREXZA (glycopyrronium) cloth, 2.4%, for topical use Initial U.S. Approval: 2018 | Journey Medical Corporation | Aphena Pharma Solutions - Maryland, LLC | 20260521 | 5 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE oral solution safely and effectively. See full prescribing information for GLYCOPYRROLATE oral solution. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Par Health USA, LLC | 20260514 | 15 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | Bryant Ranch Prepack | 20260505 | 2 |
| GLYCOPYRROLATE oral solution These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Atlantic Biologicals Corp. | 20260430 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 20260428 | 47 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | Gland Pharma Limited | 20260428 | 6 |
| These highlights do not include all the information needed to use BREZTRI AEROSPHERE safely and effectively. See full prescribing information for BREZTRI AEROSPHERE. BREZTRI AEROSPHERE ® (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2020 | AstraZeneca Pharmaceuticals LP | 20260427 | 7 |
| GLYCOPYRROLATE INJECTION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Sagent Pharmaceuticals | 20260420 | 3 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | Bryant Ranch Prepack | 20260403 | 12 |
| Glycopyrrolate Oral Solution 1 mg/5 mL | Sun Pharmaceutical Industries, Inc. | Suven Pharmaceuticals Limited | 20260402 | 5 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | Sandoz Inc | 20260401 | 11 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | REMEDYREPACK INC. | 20260326 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | REMEDYREPACK INC. | 20260326 | 5 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intravenous or intramuscular use Initial U.S. Approval: 1975 | Lifestar Pharma LLC | Mankind Pharma Limited | 20260325 | 6 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | Major Pharmaceuticals | 20260319 | 6 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Bionpharma Inc. | OrBion Pharmaceuticals Private Limited | 20260305 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | NCS HealthCare of KY, LLC dba Vangard Labs | 20260225 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE safely and effectively. See full prescribing information for GLYCOPYRROLATE. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | Bryant Ranch Prepack | 20260217 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. Glycopyrrolate tablets, for oral use Initial U.S. Approval: 1961 | Florida Pharmaceutical Products, LLC | Contract Pharmacal Corp. | 20260212 | 1 |
| Glycate | Intra-Sana Laboratories | 20260113 | 4 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLET safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLET. GLYCOPYRROLATE TABLETS, for oral use Initial U.S. Approval: 1961 Rx only | Bryant Ranch Prepack | 20260107 | 100 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLET safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLET. GLYCOPYRROLATE TABLETS, for oral use Initial U.S. Approval: 1961 Rx only | Bryant Ranch Prepack | 20260107 | 100 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | AJENAT PHARMACEUTICALS LLC | 20251229 | 2 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Jvet Pharmaceuticals LLC | GLAND PHARMA LIMITED | 20251219 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLET safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLET. GLYCOPYRROLATE TABLETS, for oral use Initial U.S. Approval: 1961 Rx only | REMEDYREPACK INC. | 20251217 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | Aurolife Pharma LLC | APL HEALTHCARE LIMITED | 20251211 | 9 |
| Glycopyrrolate Tablets, USP These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | Chartwell RX, LLC | 20251210 | 2 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE safely and effectively. See full prescribing information for GLYCOPYRROLATE. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | Rising Pharma Holdings, Inc. | Cohance LifesciencesLimited | 20251203 | 4 |
| GLYCOPYRROLATE ORAL SOLUTION These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution, for oral use Initial U.S. Approval: 1961 | Granules Pharmaceuticals Inc. | 20251202 | 2 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Amneal Pharmaceuticals LLC | 20251201 | 10 |
| Glycopyrrolate Injection, USP Rx only | Solco Healthcare US, LLC | 20251130 | 3 |
| Glycopyrrolate Injection, USP Rx only | Solco Healthcare US, LLC | 20251130 | 3 |
| Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | Meitheal Pharmaceuticals Inc. | 20251118 | 6 |
| Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | ProPharma Distribution | 20251107 | 1 |
| GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Henry Schein, Inc. | 20251105 | 1 |
| GLYCOPYRROLATE INJECTION, USPRx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Henry Schein, Inc. | 20251105 | 1 |
| GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Henry Schein, Inc. | 20251103 | 2 |
| Glycopyrrolate Injection, USP | Accord Healthcare, Inc., | Intas Pharmaceuticals Limited | 20251017 | 7 |
| Glycopyrrolate | Henry Schein, Inc. | 20251016 | 1 |
| Glycopyrrolate Injection, USP | Hikma Pharmaceuticals USA Inc. | 20251009 | 9 |
| Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | ProPharma Distribution | 20250918 | 1 |
| Glycopyrrolate Injection, USP Rx Only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Piramal Critical Care Inc | 20250918 | 9 |
| Glycopyrrolate Injection, USP, R x only | ProPharma Distribution | 20250915 | 1 |
| Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | ProPharma Distribution | 20250915 | 1 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) | 20250826 | 4 |
| GLYCOPYRROLATE INJECTION | Henry Schein, Inc. | 20250818 | 7 |
| GLYCOPYRROLATE INJECTION, USP | Cardinal Health 107, LLC | 20250818 | 7 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE oral solution safely and effectively. See full prescribing information for GLYCOPYRROLATE oral solution. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Precision Dose, Inc. | 20250808 | 3 |
| These highlights do not include all the information needed to use GLYRX ® -PF safely and effectively. See full prescribing information for GLYRX ® -PF. GLYRX ® -PF (glycopyrrolate injection), for intravenous or intramuscular use Initial U.S. Approval: 1975 | Exela Pharma Sciences, LLC | 20250723 | 5 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLET safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLET. GLYCOPYRROLATE TABLETS, for oral use Initial U.S. Approval: 1961 Rx only | QUAGEN PHARMACEUTICALS LLC | 20250614 | 4 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets, for oral use Initial U.S. Approval: 1961 | American Health Packaging | 20250518 | 3 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS, USP safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS, USP.GLYCOPYRROLATE TABLETS, USP for oral use Initial U.S. Approval: 1961 | Leading Pharma, LLC | VelZen Pharma Pvt Ltd. | 20250425 | 18 |
| GLYCOPYRROLATE ORAL SOLUTION These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution, for oral use Initial U.S. Approval: 1961 | Chartwell RX, LLC | 20250417 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20250417 | 2 |
| Glycopyrrolate Tablets, USP Rx only HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. Initial U.S. Approval: 1961 | AvPAK | 20250304 | 4 |
| 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | Caplin Steriles Limited | 20250125 | 5 |
| GLYCOPYRROLATE INJECTION | HF Acquisition Co LLC, DBA HealthFirst | 20250108 | 3 |
| GLYCOPYRROLATE INJECTION, USP 4mg/20mL (0.2mg/mL) CONTAINS BENZYL ALCOHOL 20mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20250108 | 3 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20250106 | 102 |
| These highlights do not include all the information needed to use CUVPOSA ® safely and effectively. See full prescribing information for CUVPOSA. CUVPOSA (glycopyrrolate) oral solution Initial U.S. Approval: 1961 | Merz Pharmaceuticals, LLC | 20241219 | 20 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE TABLETS for oral use Initial U.S. Approval: 1961 | Bryant Ranch Prepack | 20241212 | 102 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution, for oral use Initial U.S. Approval: 1961 | Saptalis Pharmaceuticals, LLC. | 20241112 | 2 |
| Glycopyrrolate Injection, USP | Fresenius Kabi USA, LLC | 20241014 | 3 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20241009 | 103 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20241009 | 106 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20241008 | 103 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20241004 | 101 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Bryant Ranch Prepack | 20241004 | 103 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 20240831 | 2 |
| GLYCOPYRROLATE TABLETS, USP Rx only | Endo USA, Inc. | 20240819 | 6 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | Bryant Ranch Prepack | 20240529 | 102 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE INJECTION safely and effectively. See full prescribing information for GLYCOPYRROLATE INJECTION. GLYCOPYRROLATE injection, for intramuscular or intravenous use Initial U.S. Approval: 1961 | Fresenius Kabi USA, LLC | 20240514 | 7 |
| These highlights do not include all the information needed to use PREVDUO® safely and effectively. See full prescribing information for PREVDUO®. PREVDUO® (neostigmine methylsulfate and glycopyrrolate) injection, for intravenous use Initial U.S. Approval: 2023 | Endo USA | 20240410 | 2 |
| GLYCOPYRROLATE INJECTION, USP 0.2mg/mL CONTAINS BENZYL ALCOHOL | HF Acquisition Co LLC, DBA HealthFirst | 20240222 | 8 |
| GLYCOPYRROLATE INJECTION, USP | American Regent, Inc. | 20240207 | 11 |
| GLYCOPYRROLATE INJECTION, USP 0.4mg/2mL (0.2mg/mL) 2mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20240130 | 2 |
| GLYCOPYRROLATE INJECTION, USP 1mg/5mL (0.2mg/mL) 5mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20240122 | 4 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE oral solution safely and effectively. See full prescribing information for GLYCOPYRROLATE oral solution. GLYCOPYRROLATE oral solution Initial U.S. Approval:1961 | Bryant Ranch Prepack | 20240112 | 101 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | NorthStar RxLLC | Annora Pharma Private Limited | 20240110 | 2 |
| Glycopyrrolate Tablets, USP 1.5 mg | FH2 Pharma LLC | LGM Pharma Solutions, LLC | 20231231 | 3 |
| GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20231102 | 1 |
| Glycopyrrolate Injection | XIROMED LLC | CHEMO RESEARCH,S.L. | UNIVERSAL FARMA SL | 20231023 | 3 |
| Glycopyrrolate Injection, USP | Fresenius Kabi USA, LLC | 20230922 | 4 |
| Glycopyrrolate Injection, USP | Fresenius Kabi USA, LLC | 20230816 | 4 |
| Glycopyrrolate Injection, USP | Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC | 20230816 | 8 |
| GLYCOPYRROLATE TABLETS USP | Bryant Ranch Prepack | 20230606 | 7 |
| GLYCOPYRROLATE INJECTION, USP | Medical Purchasing Solutions, LLC | 20230601 | 3 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230601 | 4 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230523 | 4 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230523 | 4 |
| Glycopyrrolate Injection, USP | Medical Purchasing Solutions, LLC | 20230515 | 2 |
| Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230515 | 2 |
| Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230515 | 2 |
| Glycopyrrolate Injection, USP | Medical Purchasing Solutions, LLC | 20230511 | 2 |
| Rx ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230509 | 2 |
| Glycopyrrolate injection, USP | Medical Purchasing Solutions, LLC | 20230508 | 2 |
| Glycopyrrolate Injection, USP | Medical Purchasing Solutions, LLC | 20230504 | 2 |
| Glycopyrrolate Injection, USP | Medical Purchasing Solutions, LLC | 20230504 | 2 |
| GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230504 | 2 |
| Glycopyrrolate Injection, USP, R x only | Medical Purchasing Solutions, LLC | 20230503 | 2 |
| Glycopyrrolate | LGM PHARMA SOLUTIONS, LLC | 20230427 | 2 |
| Glycopyrrolate Injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230425 | 4 |
| GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Medical Purchasing Solutions, LLC | 20230424 | 3 |
| These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively. See full prescribing information for BEVESPI AEROSPHERE. BEVESPI AEROSPHERE ® (glycopyrrolate and formoterol fumarate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2016 | AstraZeneca Pharmaceuticals LP | 20230324 | 26 |
| GLYCOPYRROLATE INJECTION, USP | Civica, Inc. | American Regent, Inc. | 20230301 | 3 |
| GLYCOPYRROLATE INJECTION, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20230216 | 3 |
| Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | Meitheal Pharmaceuticals Inc. | 20230112 | 1 |
| GLYCOPYRROLATE TABLETS USP | Quinn Pharmaceuticals | 20221220 | 9 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE TABLETS safely and effectively. See full prescribing information for GLYCOPYRROLATE TABLETS. GLYCOPYRROLATE tablets for oral use Initial U.S. Approval: 1961 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Appco Pharma LLC | 20221110 | 7 |
| Glycopyrrolate injection, USP | A-S Medication Solutions | 20221006 | 2 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 20220713 | 1 |
| These highlights do not include all the information needed to use GLYCOPYRROLATE ORAL SOLUTION safely and effectively. See full prescribing information for GLYCOPYRROLATE ORAL SOLUTION. GLYCOPYRROLATE oral solution Initial U.S. Approval: 1961 | Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | 20220614 | 1 |
| GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Xiromed LLC | Gland Pharma Limited | 20220412 | 6 |
| GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Xiromed, LLC | Gland Pharma Limited | 20220412 | 3 |
| GLYCOPYRROLATE INJECTION, USP | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 20220323 | 6 |
| GLYCOPYRROLATE INJECTION, USP | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 20220304 | 10 |
| NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | BE Pharmaceuticals Inc. | Caplin Steriles Limited | 20220224 | 1 |
| Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | Somerset Therapeutics, LLC | Caplin Steriles Limited | 20220127 | 12 |